| |
|
|
|
| collagen vascular diseases; congenital systemic-to-pulmonary shunts (eg, congenital heart disease); portal hypertension; human immunodeficiency virus ... |
|
|
|
|
| HIV-associated myocarditis Dilated Cardiomyopathy Endocarditis Coronary heart disease Pulmonary hypertension Cardiac neoplasms Pericardial effusions |
|
|
|
|
| Pulmonary hypertension may be classified into 3 rough categories, pre- symptomatic/compensating, symptomatic/decompensating, and declining/ decompensated. ... |
|
|
|
|
| PowerPoint Presentation on How Should One Decide Whom to Treat for Hypertension? or PowerPoint Presentation on Hypertension |
|
|
|
|
| to repeated infections (especially psuedomonas), bronchiectasis, and decline in lung function, causing respiratory failure often with a component of pulmonary hypertension |
|
|
|
|
| Powerpoint slide Presentation on Part 1 |
|
|
|
|
| PowerPoint Presentation on The Pulmonary Artery Catheter in Critical Care or PowerPoint Presentation on |
|
|
The ECG
| | Author: Anonymous |
| Institution : |
|
|
| pulmonary stenosis, chronic lung disease; Acute pulmonary embolism (E.C.G. changes may resolve with recovery from acute disease) Causes of ‘P mitrale’ |
|
|
|
|
| ... Pulmonary hypertension associated with pulmonary vascular disorders; Atrial myxoma; Diastolic dysfunction of uncertain origin; Obesity … |
|
|
|
|
| Inhaled nitric oxide is used to alleviate pulmonary hypertension and hypoxaemia, but generates toxic free radicals and oxides of nitrogen (NOx), ... |
|
|
